Mediators involved in the cancer anorexia-cachexia syndrome:: past, present, and future

被引:71
|
作者
Argilés, JM [1 ]
Busquets, S [1 ]
García-Martínez, C [1 ]
López-Soriano, FJ [1 ]
机构
[1] Univ Barcelona, Canc Res Grp, Dept Bioquim & Biol Mol, Fac Biol, Barcelona, Spain
关键词
cytokines; transcriptional factors; therapeutical strategies;
D O I
10.1016/j.nut.2005.02.003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The cachectic syndrome, characterized by a marked weight loss, anorexia, asthenia, and anemia is invariably associated with the presence and growth of the tumor and leads to a malnutrition status due to the induction of anorexia or decreased food-intake. In addition, the competition for nutrients between the tumor and the host leads to an accelerated starvation state, which promotes severe metabolic disturbances in the host, including hypermetabolism, which leads to an increased energetic inefficiency. Although the search for the cachectic factor(s) started a long time ago, and although many scientific and economic efforts have been devoted to its discovery, we are still a long way from knowing the whole truth. Present investigation is devoted to revealing the different signaling pathways, in particular transcriptional factors involved in muscle wasting. The main aim of the present review is to summarize and evaluate the different molecular mechanisms and catabolic mediators (both Immoral and tumoral) involved in cancer cachexia since they may represent targets for future promising clinical investigations. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:977 / 985
页数:9
相关论文
共 50 条
  • [1] Emerging signaling mediators in the anorexia-cachexia syndrome of cancer
    Talbert, Erin E.
    Guttridge, Denis C.
    TRENDS IN CANCER, 2022, 8 (05): : 397 - 403
  • [2] THE CANCER ANOREXIA-CACHEXIA SYNDROME
    NELSON, KA
    WALSH, D
    SHEEHAN, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 213 - 225
  • [3] The cancer anorexia-cachexia syndrome
    Nelson, KA
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 64 - 68
  • [4] Modern management of the cancer anorexia-cachexia syndrome
    Nelson K.A.
    Current Pain and Headache Reports, 2001, 5 (3) : 250 - 256
  • [5] The cancer anorexia-cachexia syndrome: myth or reality?
    Lasheen, Wael
    Walsh, Declan
    SUPPORTIVE CARE IN CANCER, 2010, 18 (02) : 265 - 272
  • [6] Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome
    Dev, Rony
    Amano, Koji
    Naito, Tateaki
    Del Fabbro, Egidio
    CURRENT ONCOLOGY REPORTS, 2024, 26 (07) : 762 - 772
  • [7] Cancer-Related Anorexia-Cachexia Syndrome
    Walz, Debra A.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2010, 14 (03) : 283 - 287
  • [8] Cancer anorexia-cachexia syndrome: cytokines and neuropeptides
    Ramos, EJB
    Suzuki, S
    Marks, D
    Inui, A
    Asakawa, A
    Meguid, MM
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (04): : 427 - 434
  • [9] Animal models of the cancer anorexia-cachexia syndrome
    Bennani-Baiti, Nabila
    Walsh, Declan
    SUPPORTIVE CARE IN CANCER, 2011, 19 (09) : 1451 - 1463
  • [10] The cancer anorexia-cachexia syndrome: myth or reality?
    Wael Lasheen
    Declan Walsh
    Supportive Care in Cancer, 2010, 18 : 265 - 272